Detalhe da pesquisa
1.
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
Lancet
; 401(10392): 1941-1950, 2023 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105210
2.
Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.
Br J Dermatol
; 190(2): 258-265, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792727
3.
Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.
J Am Acad Dermatol
; 88(4): 808-815, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36543626
4.
Evolution of Bullous Pemphigoid Clinical Pattern over Time: A 17-Year Single-Centre Retrospective Survey of 312 Cases.
Dermatology
; 239(2): 235-240, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36481737
5.
Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients.
Dermatology
; 239(1): 132-139, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36349768
6.
Anti-BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis.
J Eur Acad Dermatol Venereol
; 37(6): 1207-1214, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802102
7.
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case-control study.
Ann Rheum Dis
; 81(10): 1445-1452, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788496
8.
Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohort.
J Am Acad Dermatol
; 86(2): 345-352, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153388
9.
A localized salt-dependent aquagenic urticaria successfully treated with omalizumab.
Clin Exp Dermatol
; 47(12): 2339-2341, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36131614
10.
A new case of photoallergic contact dermatitis caused by benzophenones in magazine covers.
Contact Dermatitis
; 86(4): 300-307, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089601
11.
Benefit/risk Ratio of Low-dose Methotrexate in Cutaneous Lesions of Mycosis Fungoides and Sézary Syndrome.
Acta Derm Venereol
; 101(2): adv00384, 2021 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33313939
12.
Methotrexate-induced Primary Cutaneous Diffuse Large B-cell Lymphoma in Patients with Erythrodermic Cutaneous T-cell Lymphoma.
Acta Derm Venereol
; 100(15): adv00226, 2020 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32516423
13.
Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study).
Br J Dermatol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38660811
14.
Cutaneous localization of angioimmunoblastic T-cell lymphoma may masquerade as B-cell lymphoma or classical Hodgkin lymphoma: A histologic diagnostic pitfall.
J Cutan Pathol
; 46(2): 102-110, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370547
15.
Low- vs. Middle-dose Total Skin Electron Beam Therapy for Mycosis Fungoides: An Efficiency-based Retrospective Survey of Skin Response.
Acta Derm Venereol
; 99(6): 544-550, 2019 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30653243
16.
Case report: A severe repeated open application test reaction to an ingredient of cosmetic.
Contact Dermatitis
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38740569
17.
Allergic contact dermatitis to zinc ricinoleate in a 'natural' deodorant.
Contact Dermatitis
; 91(1): 76-78, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553652
18.
A non-cosmetic allergic contact dermatitis to ethylhexylglycerin.
Contact Dermatitis
; 90(3): 310-312, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38017612
19.
Allergic contact dermatitis to isobornyl acrylate in a hospital wristband.
Contact Dermatitis
; 91(1): 62-64, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448369
20.
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Lancet
; 389(10083): 2031-2040, 2017 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28342637